ABSTRACT: Vibrio cholerae has long been reported as an important cause of death in developing countries. The study detected the virulence and antibiotic resistance gene of eight V. cholerae isolates through in silico tools. Cholera toxins, ctxA and ctxB were found in six isolates (75%). Seventy-five percent isolates were also found to be positive for zonula occludens toxin, zot which is known to increase the permeability by altering the tight junction of the small intestine. Accessory cholera enterotoxin ace, responsible for fluid accumulation, was detected in four V. cholerae strains. Seven isolates (87.5%) were positive for toxin-coregulated pilus, tcp which helps the bacteria to adhere to gut mucosa. Both ompW and toxR genes were found in 87.5% of the isolates. Twenty-five percent isolates harboured strA, strB, sulII, dfrA1, floR genes and SXT element demonstrating that they were multidrug-resistant (MDG) bacterium. One isolate was found to be positive for tetA gene while no erythromycin resistance gene, ermA and ermB was found. Virulence genes were found in all genotypes indicating that their distribution was not genotypeoriented while genotype 2 harboured no antibiotic resistance genes. This data helps to predict virulence genes associated with cholera and also demonstrates the presence of antibiotic resistance genes. Bacteria acquired the antibiotic resistance gene through natural process which cannot be stopped. So by analyzing the resistance pattern we can choose appropriate antibiotics. In silico study helps us to predict the antibiotic resistant genotypes and can easily identify antibiotic resistant strains which help us to treat cholera infections and reduce the morbidity and mortality rate of the infected individuals.
INTRODUCTION
Gram-negative Vibrio cholerae is responsible for causing water-borne diarrheal disease cholera in healthy communities especially in developing countries. More than 100000 people die annually due to cholera. 1 Rahmani et al. reported that O1 or O139 serogroup of toxigenic V. cholerae is mainly responsible for epidemic forms of cholera. 2 On the other hand, non-O1/non-O139 serogroups of V. cholera is associated with sporadic diarrhoeal disease and responsible for mild to severe morbidity. [3] [4] [5] Ingestion of contaminated food and water caused this acute intestinal infection namely cholera. 6 Estuarine, and fresh water environments harboured V. cholerae isolates which were associated with endemic, epidemic and pandemic forms of cholera. [7] [8] [9] V. cholerae produces several virulence factors such as cholera toxin encoding element (CTX), which encodes cholera toxin (CT) 10 and the pathogenicity island toxin coregulated pilus (TCP). Acquisition of appropriate virulence genes converts nontoxigenic environmental strains into pathogenic V. cholera strain. 11 These genetic changes affect the presence and expression of virulence genes in V. cholerae. Several studies found the variability of virulence factors between environmental and clinical V. cholerae isolates. 8, 12, 13 Appropriate treatment is necessary to reduce the mortality rate of cholera patients and mortality rate may be increased from less than 1% to 50-60% with untreated cholera. 16, 24, 25 But incorrectly prescribed antibiotics contribute to the development of resistant bacteria. Changes in antibiotic-induced gene expression can increase virulence, while increased horizontal gene transfer and mutagenesis promote antibiotic resistance and spread. Low levels of antibiotics have been shown to contribute to strain diversification in organisms. In silico modelling is a logical extension of controlled in vitro experimentation in which computer models are developed to model a pharmacologic or physiologic process. The computing power is used by the research scientist for computational model experiments which continually decrease overall cost. Unlike in vivo and in vitro experiments, in silico modelling is not bound to address ethical issues. In silico models, therefore, allow the researcher to include a virtually unlimited array of parameters, which render the results more applicable to the organism as a whole. This in silico study approach has the potential to predict effective antibiotics while reducing the need for expensive lab work and clinical trials.
The aim of the study was to identify the disease associated virulence genes in 8 V. cholerae strains and also detect the antibiotic resistance genes and SXT element for successful treatment of V. cholerae infections.
METHODS AND MATERIALS
Strains used in the study: Strains used in the study are summarized in Table 1 . PCR amplification: All primers used are listed in Table 2 and Table 3 . An online software, available at http://insilico.ehu.eus/PCR/ was used to perform in silico PCR amplification. PFGE digestion: Pulse-field gel electrophoresis (PFGE) digestion and construction of the dendrogram was done in silico using the website http://insilico.ehu.es/digest/. 33, 34 The enzyme used for the digestion was SgrDl and lambda ladder was used to compare the bands.
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RESULTS AND DISCUSSION
Pulsed-field gel electrophoresis (PFGE) analysis was performed to determine the genetic diversity of the isolates. Restriction enzyme SgrDI was used that recognized the CG'TCGA_CG restriction sequence. Bands were separated according to their molecular weight in 1.2% agarose gel and lambda ladder was used to compare the band size. Results were scored into binary data and interpreted by SPSS software (IBM, USA) to construct a dendrogram (Figure 1 ). Isolates were grouped into 3 genotypes. Genotype 1 contained 50% of the isolates. Genotype 2 and 3 harboured 12.5% and 37.5% of the isolates, respectively ( Figure 2 ).
Detection of virulence genes is important for treating V. cholerae infections. Several studies documented that cholera toxin, ctx play role in diarrheal pathogenesis by inducing dehydration. 35, 36 A number of virulence factors are involved in cholera pathogenesis which mediate the bacterium to colonize the epithelium layer of the small intestine and disrupt the ion balance by producing enterotoxins. 26 Blackstone et al. stated that epidemic cholera caused life threating cholera gravis. V. cholera harbouring the cholera toxin, ctxAB is involved directly in the pathogenesis of diarrhea. 37 Previous study detected 85% ctxA gene by multiplex PCR technique 38 while another study found ctxB gene in 90.8% of the isolates. 39 The present study found that 75% isolates (n=6) had both ctxA and ctxB genes and they gave 564 bp and 391 bp gene product, respectively. in rabbit ileal loops. 42 Our study found four ace positive V. cholerae strains. Each genotype carried all four genes as mentioned above. Genotype 2 was composed of only NC_009456 Vibrio cholerae O395 chromosome 1 isolate and this strain harboured all four virulence genes (100%) (Figure 3 ). Fifty percent isolates present in genotype 1 expressed ctxA, ctxB, zot and ace genes. All the isolates present in genotype 3 carried ctxA, ctxB and zot genes but ace gene was present in about 33.33% of the isolates in genotype 3.
Sharma and Chaturvedi reported that toxincoregulated pilus, tcp is regulated with cholera toxin (CT) and also stated that continuously cholera producing Vibrio carried the tcp gene. 43 Another study found that the pilus tcp was involved in adherence of human gut mucosa. 44 Previous study found that ctx and tcp genes are associated with clinical strains of V. cholerae O1 and O139 serogroups. 45 Strains of non-O1 and non-O139 V.
cholerae isolated from water in Brazil harboured only one tcp positive strains and carried no ctxA, zot and acegene. 46 Seven isolates were found to harbour toxin-coregulated pilus, tcp with 295 bp gene product. So, the prevalence of percentage was 87.5%. Nany et al. stated that genetic sequence of the ompW gene remained constant among different V. cholerae isolates and was considered as an important genetic marker. 47 Saleh et al. study found that all clinical and environmental isolates harboured ompW genes. 48 Another study found that ompW gene was present in all V. cholerae O1 and non-O1 isolates 49 while serotypes O1, O139, and Non-O1/O139 were also found to be positive for ompW gene. 50 The ompW gene confirmed the biochemical identification of V. cholerae as it acts as an internal control. 8, 51 Present study recorded that 87.5% isolates had the ompW gene. Cholera toxin, ctx and toxin co-regulated pilus, tcp is regulated by transcription activating factor toxR gene. 38 Present study found that 87.5% isolates had the toxR gene. The genes tcp and ompW were encountered at higher prevalence in genotype 3 while 25% isolates in genotype 3 carried toxR genes ( Figure 4 Hochhut et al. stated that in case of cholera treatment, oral rehydration is effective but antibiotic reduces the disease progression and decreases the severity of the symptoms in developing countries.
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Many developing countries acquired resistance to trimethoprim, sulfamethoxazole and chloramphenicol antibiotics which have been used for cholera treatment. 25, 52, 53 Eight V. cholerae isolates were screened for antibiotic resistance genes in the SXT element. Sixty-two kb conjugative, self-transmissible SXT-C encoded resistance to sulfomethoxazole, 23 Previous study reported that the primary antibiotic oxytetracycline is used for cholera treatment. 52, 56 Only one isolate was found to harbour tetracycline resistance gene tetA and it produced a 957 bp gene product. A recent study found no ermA gene and 90% of V. cholerae isolates harboured the ermB gene. 57 The present study found that isolates showed no amplification for the ermA and ermB genes. So, erythromycin is a good choice for treating cholera infections. Antibiotic resistance genes were not found in genotype 2 ( Figure 5 ). Twenty-five percent isolates in genotype 1 expressed all 7 antibiotic resistance genes while about 33.33% isolates in genotype 3 carried all antibiotic resistance gene except tetA gene. 
CONCLUSION
Avoiding infections may be the best way to reduce the amount of antibiotics that have to be used and to reduce the likelihood that resistance will develop during therapy. Drug-resistant infections may be prevented through immunization, safe food preparation, hand washing, and using antibioticsonly when necessary. Preventing infections may also prevent the spread of resistant bacteria. This study can be used as an alternative for identification of toxigenic and pathogenic V. cholerae isolates with high specificity. The extraordinary health benefits that have so far been achieved with antibiotics have been threatened by rapidly emerging resistant bacteria. Overuse of antibiotics created this crisis. Perhaps the way antibiotics are used needs to be changed to slow down the development and spread of antibiotic-resistant infections. Stopping even some of the inappropriate and unnecessary use of antibiotics would help greatly in slowing down the spread of resistant bacteria. This study provided information to choose appropriate antibiotics for treating cholera patients. Effective antibiotic therapy reduces the chances of V. cholera for SXT element transfer to other hosts. Erythromycin can be considered as a good choice of antibiotics for treating cholera patients and reducing the mortality rate of cholera patients. 
